These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6436867)

  • 1. Cimetidine-induced alterations in desipramine plasma concentrations.
    Amsterdam JD; Brunswick DJ; Potter L; Kaplan MJ
    Psychopharmacology (Berl); 1984; 83(4):373-5. PubMed ID: 6436867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desipramine and 2-hydroxydesipramine plasma levels in endogenous depressed patients. Lack of correlation with therapeutic response.
    Amsterdam JD; Brunswick DJ; Potter L; Winokur A; Rickels K
    Arch Gen Psychiatry; 1985 Apr; 42(4):361-4. PubMed ID: 3977553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the inhibitory effect of cimetidine on desipramine metabolism between rapid and slow debrisoquin hydroxylators.
    Steiner E; Spina E
    Clin Pharmacol Ther; 1987 Sep; 42(3):278-82. PubMed ID: 3621781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Hydroxydesipramine and desipramine plasma levels: how are they related to antidepressant response?
    Stern SL; Cooper TB; Nelson LD; Johnson MH; Suckow RF
    Int Clin Psychopharmacol; 1996 Dec; 11(4):219-27. PubMed ID: 9031987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desipramine plasma concentration and therapeutic response in elderly depressives: a naturalistic pilot study.
    Kutcher SP; Shulman KI; Reed K
    Can J Psychiatry; 1986 Nov; 31(8):752-4. PubMed ID: 3791131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fluoxetine on plasma desipramine and 2-hydroxydesipramine.
    Suckow RF; Roose SP; Cooper TB
    Biol Psychiatry; 1992 Jan; 31(2):200-4. PubMed ID: 1737080
    [No Abstract]   [Full Text] [Related]  

  • 7. The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
    Cooke RG; Warsh JJ; Stancer HC; Reed KL; Persad E
    Clin Pharmacol Ther; 1984 Sep; 36(3):343-9. PubMed ID: 6467794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of 2-hydroxydesipramine plasma concentrations.
    Nelson JC; Bock JL; Jatlow PI
    Clin Pharmacol Ther; 1983 Feb; 33(2):183-9. PubMed ID: 6822031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of serum desipramine and 2-hydroxydesipramine for pharmacokinetic applications by HPLC with ultraviolet detection.
    Kenney JT; Orsulak PJ; Kolodner RM; Burton ME
    Clin Chem; 1989 Oct; 35(10):2134-6. PubMed ID: 2791284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cimetidine interaction with imipramine and nortriptyline.
    Henauer SA; Hollister LE
    Clin Pharmacol Ther; 1984 Feb; 35(2):183-7. PubMed ID: 6692646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant activity of 2-hydroxydesipramine.
    Nelson JC; Mazure C; Jatlow PI
    Clin Pharmacol Ther; 1988 Sep; 44(3):283-8. PubMed ID: 3416551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Hydroxydesipramine and desipramine plasma levels and electrocardiographic effects in depressed younger adults.
    Stern SL; Ribner HS; Cooper TB; Nelson LD; Johnson MH; Suckow RF
    J Clin Psychopharmacol; 1991 Apr; 11(2):93-8. PubMed ID: 2056147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of desipramine and 2-hydroxydesipramine on depolarization-induced calcium uptake in synaptosomes from rat limbic sites.
    Beauchamp G; Lavoie PA; Elie R
    Can J Physiol Pharmacol; 1995 May; 73(5):619-23. PubMed ID: 7585328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom exacerbation in psychotically depressed adolescents due to high desipramine plasma concentrations.
    Conrad CD; Kudler HS
    J Clin Psychopharmacol; 1986 Jun; 6(3):161-4. PubMed ID: 2872236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of 2-hydroxydesipramine by high-performance liquid chromatography.
    Wong SH; McCauley T; Kramer PA
    J Chromatogr; 1981 Nov; 226(1):147-54. PubMed ID: 7320140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of imipramine, desipramine and their hydroxy metabolites by reversed-phase chromatography with ultraviolet and coulometric detection.
    Foglia JP; Sorisio D; Perel JM
    J Chromatogr; 1991 Dec; 572(1-2):247-58. PubMed ID: 1818058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases.
    Devane CL; Wolin RE; Rovere RA; Panahon NC; Sutfin TA; Jusko WJ
    J Clin Psychiatry; 1981 Apr; 42(4):143-7. PubMed ID: 7204359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass fragmentographic determination of lofepramine and its metabolites in human plasma and urine using deuterated internal standards.
    Matsubayashi K; Hakusui H; Sano M
    J Chromatogr; 1977 Nov; 143(6):571-80. PubMed ID: 914949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.